|Bid||170.94 x 900|
|Ask||171.00 x 1000|
|Day's Range||169.84 - 171.02|
|52 Week Range||94.00 - 171.02|
|Beta (5Y Monthly)||1.27|
|PE Ratio (TTM)||55.43|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Alexion (ALXN) delivered earnings and revenue surprises of 14.29% and 4.49%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?